MIKAYLA WILLIAM: Open Payments
NPI 1003392895 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 8 payments from 5 companies in 2025. Trend: 2023 $440 · 2024 $376 · 2025 $335
Food & beverage: $257Education: $78
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $143 |
| ABBVIE INC. | 1 | $78 |
| Genmab U.S., Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
Products named: BLINCYTO, VENCLEXTA, Epkinly, Vanflyta.
Industry payments across MI — which companies pay providers there.
